Amylyx Pharmaceuticals, Inc. (AMLX)

NMS – Real vaqt narxi. Valyuta: USD

23.60

-0.03 (-0.13%)

Bozor ochiq: Aug 12, 2026, 1:33 PM EDT

24.00

+0.37 (1.57%)

Oldingi bozordan keyin: Aug 11, 2026, 7:50 PM EDT

11.08.2026

4 Biotech Stocks With Major Second-Half Pipeline Catalysts This Year

Vertex Pharmaceuticals, Amylyx Pharmaceuticals, Praxis Precision Medicines and BridgeBio Pharma face major 2026 catalysts, from FDA decisions to late-stage readouts.

07.08.2026

Amylyx Pharmaceuticals: Avexitide Defines The Endocrine Rebuild

Amylyx Pharmaceuticals (AMLX) is transitioning from its ALS legacy to a late-stage endocrine company, with avexitide as its lead asset. AMLX's $250.8M cash runway extends into 2028, supporting LUCIDITY Phase 3 readout, regulatory submission, and potential 2027 launch without near-term financing risk. LUCIDITY's pivotal trial targets post-bariatric hypoglycemia, a large orphan market with no approved therapies; topline results expected late August or early September 2026.

06.08.2026

Amylyx Pharmaceuticals, Inc. (AMLX) Q2 2026 Earnings Call Transcript

06.08.2026

Amylyx Pharmaceuticals Q2 Earnings Call Highlights

Amylyx Pharmaceuticals NASDAQ: AMLX said its pivotal Phase III LUCIDITY trial of avexitide in post-bariatric hypoglycemia, or PBH, has completed final patient visits, with top-line data expected in late August or early September.

06.08.2026

Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results.

03.08.2026

Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026.

Videolar

No Data

There is no data to display

Press-relizlar

06.08.2026

Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results.

Amylyx Pharmaceuticals, Inc. (AMLX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Amylyx Pharmaceuticals, Inc. (AMLX)

4 Biotech Stocks With Major Second-Half Pipeline Catalysts This Year

Amylyx Pharmaceuticals: Avexitide Defines The Endocrine Rebuild

Amylyx Pharmaceuticals, Inc. (AMLX) Q2 2026 Earnings Call Transcript

Amylyx Pharmaceuticals Q2 Earnings Call Highlights

Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results

Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026

Videolar

No Data

Press-relizlar

Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results

4 Biotech Stocks With Major Second-Half Pipeline Catalysts This Year

Amylyx Pharmaceuticals: Avexitide Defines The Endocrine Rebuild

Amylyx Pharmaceuticals, Inc. (AMLX) Q2 2026 Earnings Call Transcript

Amylyx Pharmaceuticals Q2 Earnings Call Highlights

Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results

Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026

Videolar

No Data

Press-relizlar

Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results

Search stocks

Amylyx Pharmaceuticals, Inc. (AMLX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Amylyx Pharmaceuticals, Inc. (AMLX)

4 Biotech Stocks With Major Second-Half Pipeline Catalysts This Year

Amylyx Pharmaceuticals: Avexitide Defines The Endocrine Rebuild

Amylyx Pharmaceuticals, Inc. (AMLX) Q2 2026 Earnings Call Transcript

Amylyx Pharmaceuticals Q2 Earnings Call Highlights

Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results

Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026

Videolar

No Data

Press-relizlar

Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results

4 Biotech Stocks With Major Second-Half Pipeline Catalysts This Year

Amylyx Pharmaceuticals: Avexitide Defines The Endocrine Rebuild

Amylyx Pharmaceuticals, Inc. (AMLX) Q2 2026 Earnings Call Transcript

Amylyx Pharmaceuticals Q2 Earnings Call Highlights

Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results

Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026

Videolar

No Data

Press-relizlar

Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results